Trials / Completed
CompletedNCT00744718
Bevacizumab and Carboplatin for Patients With Ovarian Cancer
Bevacizumab and Carboplatin for Patients With Platin Resistant Epithelial Ovarian Cancer. A Phase II Study.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 73 (actual)
- Sponsor
- Vejle Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a phase II trial to investigate the effect of bevacizumab and carboplatin in patients with platin resistant ovarian cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bevacizumab | Bevacizumab 10 mg/kg every 3 weeks |
| DRUG | Carboplatin | Carboplatin AUC 5 every 5 weeks |
Timeline
- Start date
- 2008-08-01
- Primary completion
- 2015-08-01
- Completion
- 2015-12-01
- First posted
- 2008-09-01
- Last updated
- 2016-11-16
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00744718. Inclusion in this directory is not an endorsement.